Search This Blog

Tuesday, May 4, 2021

Glaxo: ViiV Starts Rolling Submission Of NDA for HIV Preventive

 GSK - VIIV HEALTHCARE INITIATES ROLLING SUBMISSION OF NEW DRUG APPLICATION WITH US FDA FOR LONG-ACTING CABOTEGRAVIR FOR PREVENTION OF HIV Source text: bit.ly/3tbvm8w

https://www.reuters.com/article/brief-gsk-says-viiv-healthcare-starts-ro-idUSFWN2MR0CZ

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)